This document discusses global healthcare spending and issues with efficiency. It notes that healthcare costs are a large government expenditure and that many countries struggle with delivery issues. Specific examples call out the US having nearly $1 trillion in annual waste and inefficiency in its system. Canada is noted as needing to review rising drug costs that account for nearly half of its public healthcare spending. Other countries like the UK and Australia are highlighted as having more efficient systems through cost controls like drug caps and a focus on front-line services over administration.